Video - Rett syndrome

Back to full view

00:00 / 00:00

More Videos

Video Summary

Rett syndrome, originally termed cerebroatrophic hyperammonemia, is a rare genetic neurological disorder of the gray matter of the brain that almost exclusively affects females, though it has also been found in male patients. It is caused by a mutation of the MECP2 gene and is inherited in an X-linked dominant pattern.

The symptoms of Rett syndrome typically appear between 6 and 18 months of age and include slowed growth, loss of language and social skills, and the development of repetitive hand movements. Other symptoms can include seizures, scoliosis, and breathing abnormalities.

The diagnosis of Rett syndrome is based on a genetic test looking for the MECP2 mutation, and the treatment focuses on managing symptoms with selective serotonin reuptake inhibitors (SSRIs) to help manage behavioral issues. Additionally, a multidisciplinary team that includes occupational, speech, and physical therapists can help optimize a child's life.

Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX